$MANE

$140.72 +$3.33 (2.42%) Close

$MANE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 41.8M shares outstanding

Who owns MANE?

By type of holder

Institutions 81.2% Insiders 16.4% Everyone else 2.4%

Concentration Top 10 holders own 79.4%

Patrick G. Enright 11.1% · Juliet Tammenoms Bakker 11.1%

Institutional ownership

81.2%

+19.2 pts vs last qtr

Institutional holders

163

+82 vs last qtr

Net shares bought

+8.0M

by institutions in Q2 2026

New / sold out

96 / 14

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Deep Track Capital, LP +1.5M
FMR LLC +1.4M

Biggest sellers in Q2 2026

Adage Capital Partners GP, L.L.C. −550.3K
Paradigm Biocapital Advisors LP SOLD OUT −525.0K

Who is planning to sell?

Notices of proposed sale, last 12 months

$151M

7 notices from 7 people

Shares covered

1.4M

3.34% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Averill Master Fund, Ltd. Affiliate $74.1M
SR One Capital Fund II Aggregator, LP Shareholder $23.7M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+1.1%

+1.09% a year

Each share's claim on the business

−1.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.69M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

29.1%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting MANE on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MC Montanova Capital, LLC 13D · 8.8%	4.2M	9.98%	Unchanged	Q1 '26	9.4%
Shares held by quarter Peak holding4.2M (Q1'26) Change over 8 quarters+4.2M Share of the company9.980% Disclosed stake13D · 8.8% Montanova Capital, LLC's full portfolio →
F FMR LLC	3.2M	7.67%	+1.4M (+78.8%)	Q1 '26	0.0%
Shares held by quarter Peak holding3.2M (Q2'26) Change over 8 quarters+3.2M Share of the company7.670% FMR LLC's full portfolio →

Montanova Capital, LLC

13D · 8.8%

4.2M

% of company

9.98%

Change vs last qtr

Unchanged

Held since

Q1 '26

FMR LLC

3.2M

% of company

7.67%

Change vs last qtr

+1.4M (+78.8%)

Held since

Q1 '26

28 more super investors behind a free account

See every manager holding Veradermics, Incorporated, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting MANE on Form N-PORT; together they hold 18.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$76M	618.4K	1.48%	0.00%	June 30, 2026
FG Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust	$75.9M	771.4K	1.85%	0.08%	August 31, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$76M

% of company

1.48%

% of the fund

0.00%

As of

June 30, 2026

Fidelity Growth Company Fund

Fidelity Mt. Vernon Street Trust

Position value

$75.9M

% of company

1.85%

% of the fund

0.08%

As of

August 31, 2026

23 more funds behind a free account

See every fund holding Veradermics, Incorporated and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
PG Patrick G. Enright 5%+ holder 13D · 11.3%	4.7M	11.14%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company11.140% Disclosed stake13D · 11.3% View the 13D/G filing →
JT Juliet Tammenoms Bakker 5%+ holder 13D · 11.3%	4.7M	11.14%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company11.140% Disclosed stake13D · 11.3% View the 13D/G filing →

Patrick G. Enright

5%+ holder13D · 11.3%

4.7M

% of company

11.14%

Change vs last qtr

—

Held since

—

Juliet Tammenoms Bakker

5%+ holder13D · 11.3%

4.7M

% of company

11.14%

Change vs last qtr

—

Held since

—

20 more holders behind a free account

See every insider and 5%+ holder of Veradermics, Incorporated.

Comments